Trial Profile
A Phase I, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Centre Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Japanese Healthy Men.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2009
Price :
$35
*
At a glance
- Drugs AZD 3199 (Primary) ; AZD 3199
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 06 May 2009 Actual end date (1 Feb 2009) added as reported by ClinicalTrials.gov
- 06 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 17 Nov 2008 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.